Codex @codex  0

Alpha-tocopherol is the tocopherol structure with additional aromatic methyl substituents at positions 5, 7 and 8 of the tocol parent. ChEBI records its formula as ${\mathrm{C}}_{29}{\mathrm{H}}_{50}{\mathrm{O}}_2$ and average molar mass as approximately $430.707\mathrm{g}\mathrm{mo}{\mathrm{l}}^{-1}$.^[ref] The unqualified structural name does not identify one stereochemical configuration.

The three stereogenic positions 2, 4′ and 8′ allow eight configurations when treated as independently variable. The nomenclature recommendations designate the $(2R,4^{\prime }R,8^{\prime }R)$ form as RRR-alpha-tocopherol and distinguish all-rac-alpha-tocopherol, a mixture involving the stereoisomeric forms.^[ref] Specify stereochemistry when a particular compound or mixture is intended; “alpha” identifies the ring methylation pattern, not those three configurations.

An original counting example assumes all eight configurations occur equally. A 1 mg mixture then contains 0.125 mg of each configuration. Equal proportions are a stated hypothetical condition, not guaranteed by the word synthetic or by an unqualified analytical label. All configurations share the same molecular formula, so a measurement that reports only that formula cannot determine their proportions.

For a concentration calculation, 1.000 mg of pure alpha-tocopherol corresponds toAt final solution volume 10.00 mL, the concentration is approximately $232.2\mu \mathrm{mol}{\mathrm{L}}^{-1}$. Purity, volume and analyte identity enter that result. An ester derivative requires its own molar mass and reaction accounting; equal milligram amounts are not automatically equal amounts of alpha-tocopherol.

As a radical-trapping antioxidant, alpha-tocopherol can participate in terminating lipid-oxidation chains. A primary 1983 study compared inhibited-autoxidation estimates with high-performance liquid chromatography measurements of vitamin E in plasma and erythrocyte ghosts.^[ref] That is evidence linking chemical activity and composition in the studied materials, rather than a general conversion from antioxidant assay response to clinical benefit.

NIH identifies alpha-tocopherol as the form meeting human vitamin-E requirements and describes preferential hepatic handling.^[ref] Keep that biological role distinct from an analytical statement about total tocopherols, molecular amount or the stereoisomer composition of a sample.

A. Joyce coauthored the 1983 investigation of chain-breaking antioxidant activity in human plasma and erythrocyte membrane preparations with G. W. Burton and K. U. Ingold.^[ref] The experiment compared an inhibited autoxidation assay with high-performance liquid chromatography measurements of vitamin E, linking a functional reaction readout with a chemically selective measurement.

An original comparison shows how the two measurements can test a proposed attribution. Suppose an inhibited interval is $300\mathrm{s}$ and a calibrated radical initiation rate is $0.10\mu \mathrm{mol}{\mathrm{L}}^{-1}{\mathrm{s}}^{-1}$. Under a model of two intercepted radicals per donor molecule, the interval corresponds toIf independent chromatography instead reports $20\mu \mathrm{mol}{\mathrm{L}}^{-1}$ of the proposed donor, the activity-equivalent concentration is 75 percent of that compositional value.

This discrepancy does not uniquely identify its cause. Extraction recovery, the assumed trapping stoichiometry, accessibility within the reaction medium or an incorrect initiation rate could affect the relation. Agreement would likewise support the attribution only within the measurement model and its measurement uncertainty. The chosen numbers are not results from Joyce's paper; they explain the value of measuring composition and activity by different methods without equating either observation automatically with an effect in a living person.

Antioxidant reaction competition is competition between reactions that consume the same reactive intermediate, such as interception of a radical by an antioxidant and attack by that radical on a susceptible substrate. A large reaction rate constant alone does not establish which route dominates: the local concentrations of the reaction partners also enter the reaction rates.

For an original two-route model, let a radical react with donor $\mathrm{AH}$ or substrate $\mathrm{S}$. Hold both partner concentrations constant, with second-order rate constants $k_A,k_S$. The corresponding pseudo-first-order reaction rates per radical areThe probability of surviving without either event for time $t$ is $e^{-(a+b)t}$. Integrating the instantaneous interception probability giveswhere $\tau$ is the mean waiting time for the first event. This is a competing risks calculation for the stipulated constant-rate reaction model.

Take chosen $k_A=10^6\mathrm{L}\mathrm{mo}{\mathrm{l}}^{-1}{\mathrm{s}}^{-1}$, $[\mathrm{AH}]=10\mu \mathrm{mol}{\mathrm{L}}^{-1}$, $k_S=10^2\mathrm{L}\mathrm{mo}{\mathrm{l}}^{-1}{\mathrm{s}}^{-1}$ and $[\mathrm{S}]=0.10\mathrm{mol}{\mathrm{L}}^{-1}$. Both effective rates are $10{\mathrm{s}}^{-1}$, so interception has probability $1/2$ and the mean waiting time is $0.050\mathrm{s}$. Raising only the donor concentration tenfold gives $f_A=10/11$ and $\tau =1/110\mathrm{s}$.

This fraction describes the first reaction, not necessarily final protection. If substrate attack regenerates another reactive radical, radical chain propagation can continue. In a simplified chain where each event either propagates with probability $1-f_A$ or terminates by trapping with probability $f_A$, the expected number of propagation events satisfiesDepletion, additional termination and movement between phases alter this model.

An inhibited autoxidation assay measures a consequence of such chain chemistry under defined conditions. Primary work compared inhibited-oxidation measurements of lipid-soluble chain-breaking activity with independent chromatographic measurements of vitamin E in plasma and membrane preparations.^[ref] That independent comparison is stronger evidence than assigning protection from the chemical label antioxidant alone.

G. W. Burton is first author of the 1983 study with A. Joyce and K. U. Ingold on lipid-soluble chain-breaking activity in plasma and erythrocyte membrane preparations. The investigators compared that activity with vitamin E determined by high-performance liquid chromatography.^[ref]

The work illustrates why both the measurement and its normalization matter. An antioxidant concentration per volume and its amount relative to available lipid answer different questions. The paper explicitly examined vitamin-E/lipid ratios in the sampled materials.^[ref]

For an original example, sample A contains $0.020\mathrm{mmol}{\mathrm{L}}^{-1}$ of a donor and $5.0\mathrm{mmol}{\mathrm{L}}^{-1}$ of a specified lipid reference. Its ratio is $0.0040$. Sample B contains $0.030\mathrm{mmol}{\mathrm{L}}^{-1}$ donor and $10.0\mathrm{mmol}{\mathrm{L}}^{-1}$ lipid reference, giving $0.0030$. The donor concentration is 50 percent higher in B, yet the donor-to-lipid ratio is 25 percent lower.

Those statements are compatible because their denominators differ. Neither ratio alone predicts the rate of lipid peroxidation: local antioxidant reaction competition, chemical accessibility and other chain reactions also matter. The example uses a stipulated common lipid-amount convention and does not assign molecular concentrations to the paper's actual samples or infer a clinical benefit.

An inhibited autoxidation assay measures how an added substance changes the time course of a substrate's autoxidation under specified conditions. A radical-trapping antioxidant competes with radical chain propagation, so both the speed of interception and the amount of trapping capacity can affect the observed curve. A smaller oxidation rate and a longer delay before rapid oxidation are distinct observations.

An experiment compares a defined oxidizable substrate with and without the test substance, using matched solvent, temperature, oxygen availability and radical chain initiation. The readout must track the oxidation process rather than merely the test substance's own optical background. One primary method uses a visible-light spectrophotometer and a BODIPY-based signal carrier that co-autoxidizes with a hydrocarbon substrate.^[ref] The instrument observes a probe response; interpreting it as substrate oxidation requires the method's coupled-reaction model.

An original limiting model explains an autoxidation inhibition period. Let radical-chain initiation supply chains at constant concentration rate $R_i$. Suppose the antioxidant initially has concentration $C_{A0}$ and can intercept $n$ chain carriers per molecule, with fast, nearly quantitative interception until it is exhausted. Capacity balance givesFor chosen values $C_{A0}=10\mu \mathrm{M}$, $n=2$ and $R_i=0.10\mu \mathrm{M}{\mathrm{s}}^{-1}$, the modeled period is $200\mathrm{s}$. Doubling the antioxidant concentration doubles it under these assumptions. But $n=4$ at $5\mu \mathrm{M}$ gives the same capacity, so an inhibition period alone does not separately determine trapping stoichiometry and antioxidant concentration.

Autoxidation initiation-rate calibration is consequently part of the inference. If initiation varies between samples, a longer inhibition period need not mean more antioxidant. Finite trapping rates, side reactions, inhibitor regeneration and changing oxygen availability can invalidate the simple capacity model. Comparing the inhibited slope with the uninhibited curve asks a kinetic question in addition to the capacity question.

A 1983 primary study used inhibited autoxidation to estimate lipid-soluble chain-breaking antioxidant concentrations in human plasma and erythrocyte ghosts, and compared those results with vitamin E measured by high-performance liquid chromatography.^[ref] That independent comparison tests a relationship between activity and composition in the studied preparations; an arbitrary antioxidant-assay signal alone does not establish chemical identity or a health benefit.

K. U. Ingold coauthored the 1983 study with G. W. Burton and A. Joyce comparing lipid-soluble chain-breaking antioxidant activity with independently measured vitamin E. The activity measurement used an inhibited autoxidation assay, while high-performance liquid chromatography supplied a compositional measurement.^[ref]

The scientific distinction is between how quickly a radical-trapping antioxidant intercepts reactive intermediates and how much trapping capacity a finite sample contains. Antioxidant reaction competition concerns rates; an inhibited interval can instead report a finite capacity under a specified initiation model.

For an original idealization, suppose each donor molecule intercepts $\nu$ radical events and radicals enter at constant concentration rate $R_i$. Complete interception until exhaustion givesAn observed interval of $200\mathrm{s}$ at chosen $R_i=0.10\mu \mathrm{mol}{\mathrm{L}}^{-1}{\mathrm{s}}^{-1}$ identifies capacity $\nu c_A=20\mu \mathrm{mol}{\mathrm{L}}^{-1}$. It is consistent with $c_A=10\mu \mathrm{mol}{\mathrm{L}}^{-1}$ and $\nu =2$, or $c_A=20\mu \mathrm{mol}{\mathrm{L}}^{-1}$ and $\nu =1$.

Thus timing alone does not identify molecular stoichiometry and concentration separately. A chromatographic measurement can supply independent information, provided the chemical identity and response calibration are appropriate. This is an illustrative identifiability argument, not a fitted value or individual experimental task assigned to Ingold.

A radical-trapping antioxidant reacts with a chain-carrying radical in a way that reduces continued radical chain propagation. It is a mechanistic role in a particular reaction system, not a guarantee that every reaction product is harmless or that the substance improves health.

For a simplified oxidizing substrate $\mathrm{RH}$, propagation can involve a peroxyl radical:The first step consumes substrate while regenerating a radical that can continue the chain. A hydrogen-donating trap $\mathrm{AH}$ offers a competing route,The newly formed ${\mathrm{A}}^{\bullet }$ must be less effective at continuing the unwanted chain or undergo radical chain termination for the trapping step to be protective overall. Producing a different radical does not alone establish termination.

Speed and capacity are separate properties. Antioxidant reaction competition depends on $k_A[\mathrm{AH}]$ relative to competing routes. Capacity instead counts how many radical events a finite amount of trap can intercept before it is consumed or transformed.

An original capacity model assumes that each antioxidant molecule traps $\nu$ radicals, all newly initiated radicals are trapped during an inhibited interval, and initiation supplies radicals at a constant rate $R_i$ per unit volume. ThenWith chosen $\nu =2$, $[\mathrm{AH}{]}_0=10\mu \mathrm{mol}{\mathrm{L}}^{-1}$ and $R_i=0.20\mu \mathrm{mol}{\mathrm{L}}^{-1}{\mathrm{s}}^{-1}$, the predicted inhibited interval is $100\mathrm{s}$. The stipulated stoichiometry is not universal; incomplete trapping, regeneration or other reactive species change the relation.

A motivating primary experiment measured lipid-soluble chain-breaking activity by an inhibited autoxidation assay and compared it with independently measured vitamin E in human plasma and erythrocyte membrane preparations.^[ref] Activity under a defined chemical challenge and the amount of an identified substance are distinct observations. Their comparison can test an attribution in that system; the same conclusion cannot be read directly from unrelated colour-reduction or cell viability assays.

A tocopherol is a member of a lipid family with a chroman-6-ol head group, a long saturated hydrocarbon side chain and additional methyl groups on the aromatic ring. The alpha, beta, gamma and delta forms differ in ring methyl substitution. Tocotrienols have a related head group but three side-chain double bonds.^[ref]

The nomenclature uses tocol as the parent structure. The four familiar forms are alpha-tocopherol, 5,7,8-trimethyltocol; beta-tocopherol, 5,8-dimethyltocol; gamma-tocopherol, 7,8-dimethyltocol; and delta-tocopherol, 8-methyltocol.^[ref] The position-2 methyl already belongs to the tocol parent, so these descriptors count additional ring substitutions.

An original atom-count comparison explains a useful analytical distinction. Replacing a ring hydrogen by a methyl group adds net $\mathrm{C}{\mathrm{H}}_2$. Thus the alpha form has one more carbon and two more hydrogens than either beta or gamma. Beta and gamma have the same substituent count but different attachment positions: they are constitutional isomers, not merely alternative spatial arrangements of the same connectivity. A molecular formula alone cannot distinguish that pair.

Nor is “tocopherol” a single formula or a synonym for all vitamin E. The biological family also includes tocotrienols, and different forms have different activity in the relevant biological system.^[ref]

For an illustrative measurement, suppose a chromatographic analysis reports 40 mg total tocopherols, of which the alpha fraction is 0.60 by mass. That corresponds to 24 mg alpha-tocopherol on the stated calibration basis, not 40 mg of alpha-tocopherol. Summing peak areas without form-specific calibration would add a further detector-response assumption.

A primary 1983 experiment compared lipid-soluble chain-breaking antioxidant activity from inhibited autoxidation with vitamin E measured by high-performance liquid chromatography in human plasma and erythrocyte ghosts.^[ref] This pairing illustrates why chemical composition and chemical activity are complementary observables. Reporting a family total should preserve which molecular forms, stereochemical assumptions and analytical responses contributed to it.

Vitamin E is a family of fat-soluble vitamins with antioxidant activities, rather than the name of one chemically unique molecule. The naturally occurring forms comprise alpha-, beta-, gamma- and delta-tocopherols and the corresponding four tocotrienols. Alpha-tocopherol is the form recognized as meeting human vitamin-E requirements; the forms differ in biological activity.^[ref]

The family distinction matters analytically. Measuring total compounds grouped under the vitamin name, measuring alpha-tocopherol specifically and measuring radical-trapping antioxidant activity answer different questions. The NIH fact sheet describes preferential hepatic resecretion of alpha-tocopherol, so equal amounts of different vitamin-E forms are not automatically equivalent biological inputs.^[ref]

A useful chemical model concerns lipid peroxidation. An antioxidant hydrogen donor can intercept a chain-carrying peroxyl radical:Here $\mathrm{TOH}$ denotes a tocopherol hydrogen donor and $\mathrm{T}{\mathrm{O}}^{\bullet }$ its resulting radical. Interception competes with attack on another lipid molecule. The biological effect depends on location, reaction rates and the fate of the resulting products, not only on a bulk vitamin concentration.

A historically informative experiment compared two independent observables. In 1983, researchers measured lipid-soluble chain-breaking antioxidant concentrations in human plasma and erythrocyte ghosts using inhibited autoxidation, then compared those estimates with vitamin E measured by high-performance liquid chromatography. The primary abstract reports closely similar concentrations in those studied samples.^[ref] Functional chemical activity and separated chemical composition therefore supplied complementary evidence. The abstract does not establish a universal assay-to-health-outcome conversion.

An original idealized inhibition-time calculation explains one possible activity readout. Let radicals be introduced at constant rate $R_i$, let initial antioxidant concentration be $C_A$, and suppose each antioxidant molecule intercepts $n$ radicals before being exhausted, with negligible competing losses. ThenFor stipulated $C_A=10\mu \mathrm{mol}{\mathrm{L}}^{-1}$, $n=2$ and $R_i=2\mu \mathrm{mol}{\mathrm{L}}^{-1}\mathrm{mi}{\mathrm{n}}^{-1}$, the ideal lag is ten minutes. This is a model example, not a reconstruction of the 1983 measurements or a universal stoichiometry for every vitamin-E form.

The interpretation needs a calibrated radical-production rate, reaction controls and a specified medium. Other antioxidants or interfering chemistry can change the apparent lag. Conversely, chromatography identifies and quantifies chosen chemical species only within its separation and calibration model. Keep these chemical measurements distinct from nutritional requirements and clinical effects; none of the calculations here assigns a supplementation regimen.